Labcorp Holdings Corporate Segment — Operating Income decreased by 15.8% to -$116.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.9%, from -$132.40M to -$116.60M. Over 4 years (FY 2021 to FY 2025), Corporate Segment — Operating Income shows a downward trend with a 4.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase in operating loss indicates rising corporate overhead or centralized costs, while a decrease in loss suggests improved cost management or reduced administrative burden.
This metric represents the operating profit or loss generated by the corporate-level functions of the organization, excl...
Peers in the healthcare services sector typically report corporate expenses as a negative operating income line item, with variations based on the level of cost allocation to operating segments.
lh_segment_corporate_segment_operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$46.80M | -$97.40M | -$212.70M | -$82.90M | -$98.50M | -$111.80M | -$139.60M | -$122.20M | -$177.90M | -$169.60M | -$174.40M | -$128.90M | -$180.30M | -$172.50M | -$189.10M | -$132.40M | -$139.20M | -$109.90M | -$100.70M | -$116.60M |
| QoQ Change | — | -108.1% | -118.4% | +61.0% | -18.8% | -13.5% | -24.9% | +12.5% | -45.6% | +4.7% | -2.8% | +26.1% | -39.9% | +4.3% | -9.6% | +30.0% | -5.1% | +21.0% | +8.4% | -15.8% |
| YoY Change | — | — | — | — | -110.5% | -14.8% | +34.4% | -47.4% | -80.6% | -51.7% | -24.9% | -5.5% | -1.3% | -1.7% | -8.4% | -2.7% | +22.8% | +36.3% | +46.7% | +11.9% |